Table 2 The histopathological and clinical data of patients.

From: Decreased expression of miR-23b is associated with poor survival of endometrial cancer patients

ID

Age

Type of EC/ HE

Grading

TNM

101

53

Endometrioid EC (EC1)

G2

pT3b N0

102

66

Endometrioid EC (EC1)

G1

pT1b N0

103

60

Endometrioid EC (EC1)

G3

pT1a N1

104

46

Endometrioid EC (EC1)

G1

pT1a N0

105

60

Endometrioid EC (EC1)

G1

pT2 N0

106

70

Endometrioid EC (EC1)

G1

pT1a N0

107

63

Endometrioid EC (EC1)

G2

pT2 N0

108

68

Endometrioid EC (EC1)

G1

pT1b Nx

109

64

Endometrioid EC (EC1)

G1

pT3b N0

110

79

Endometrioid EC (EC1)

G2

pT1b N0

111

57

Endometrioid EC (EC1)

G1

pT1a N0

112

65

Endometrioid EC (EC1)

G1

pT3b N0

113

64

Endometrioid EC (EC1)

G1

pT1a N0

114

52

Endometrioid EC (EC1)

G2

pT2 N0

115

62

Endometrioid EC (EC1)

G2

pT3a N0

116

68

Endometrioid EC (EC1)

G1

pT1b N1

117

71

Endometrioid EC (EC1)

G2

pT1a N0

118

61

Endometrioid EC (EC1)

G1

pT1a N0

119

64

Serous EC (EC2)

High grade

pT3a N0

120

84

Serous EC (EC2)

n/a

pT1a N0

121

80

Serous EC (EC2)

High grade

pT3b N1a

122

79

Serous EC (EC2) + Endometrioid EC (EC1)

High grade + G1

pT3c N0 + pT1a N0

123

68

Serous EC (EC2)

High grade

pT3b N0

124

64

Serous EC (EC2)

High grade

pT1b N1

125

78

Serous EC (EC2)

High grade

pT1b Nx

126

73

Serous EC (EC2)

n/a

pT3b N1

127

84

Serous EC (EC2)

High grade

pT1a N0

128

69

Serous EC (EC2)

High grade

pT2 N1a

129

78

Serous EC (EC2)

High grade

pT3b N2

130

66

Serous EC (EC2)

High grade

pT3b N2

131

23

HE

n/a

n/a

132

46

HE

n/a

n/a

133

44

HE

n/a

n/a

134

41

HE

n/a

n/a

135

49

HE

n/a

n/a

136

50

HE

n/a

n/a

137

48

HE

n/a

n/a

138

55

HE

n/a

n/a

139

37

HE

n/a

n/a

140

51

HE

n/a

n/a

141

46

HE

n/a

n/a

142

52

HE

n/a

n/a

143

51

HE

n/a

n/a

144

47

HE

n/a

n/a

145

50

HE

n/a

n/a